Stay updated on GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:37.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The study record has been replaced by a 403 Forbidden message and a Home link, leaving the trial details unavailable.
    Difference
    0.5%
    Check dated 2026-10-05T18:13:11.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, and the detailed study content is replaced by an error screen with limited navigation.
    Difference
    20%
    Check dated 2026-09-21T22:12:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    There are no additions or deletions to report, so the page content remains unchanged. This indicates no updates to the study details were captured in the provided data.
    Difference
    0.1%
    Check dated 2026-09-07T20:47:28.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5, indicating a minor site update.
    Difference
    0.1%
    Check dated 2026-08-31T17:14:42.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    No changes were reported in the provided data.
    Difference
    0.1%
    Check dated 2026-08-24T16:53:53.000Z thumbnail image

Stay in the know with updates to GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GD2-SADA:177Lu-DOTA in GD2 Expressing Solid Tumors Clinical Trial page.